- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Metastatic Hormone-Receptor-Positive (HR ) Breast Cancer
Total 89845 results
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
Shuangyue LiuNot yet recruiting
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Myeloid TherapeuticsRecruitingEpithelial Tumors, MalignantAustralia
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Novartis PharmaceuticalsRecruitingBreast CancerUnited States
-
University of California, San FranciscoRecruitingMetastatic Breast Cancer | Lobular Breast CarcinomaUnited States
-
Carrick Therapeutics LimitedBerlin-Chemie AG Menarini GroupRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerUnited States, France, Spain, United Kingdom
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
University of MiamiRecruitingStage IV Breast Cancer | HER2-positive Metastatic Breast CancerUnited States
-
Ministry of Health, Saudi ArabiaMaher M.aklNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
NextPoint Therapeutics, Inc.RecruitingMetastatic Malignant NeoplasmUnited States
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Institut CurieSeagen Inc.RecruitingHER2-positive Breast CancerFrance
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Fudan UniversityRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | MutationChina
-
Fudan UniversityNot yet recruitingTriple-Negative Breast CancerChina
-
Daiichi Sankyo, Inc.AstraZenecaRecruiting
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Orion Biotechnology Polska Sp. z o.o.Not yet recruitingMetastatic Colorectal Cancer | Metastatic Cancer | Metastatic Breast Cancer | Metastatic Urothelial Carcinoma | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Institut Investigacio Sanitaria Pere VirgiliInstitut Català d'Oncologia; Hospital Universitario Ramon y Cajal; Hospital Arnau... and other collaboratorsRecruitingMetastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastasis | Metastatic Prostate CancerSpain
-
Shenzhen Yangli Pharmaceutical Technology Co., LtdRecruitingMetastatic Breast Cancer | ER+, HER2- Advanced Breast CancerChina
-
Fudan UniversityNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMetastatic Breast CancerItaly
-
AstraZenecaRecruiting
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingTNBC - Triple-Negative Breast CancerGermany
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, China, Spain, Hungary, Japan, Australia, Brazil, Italy, Slovakia, Switzerland
-
Samsung Medical CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Radiation Therapy ComplicationKorea, Republic of
-
AstraZenecaRecruitingBreast CancerRussian Federation
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Mary D ChamberlinDartmouth-Hitchcock Medical CenterNot yet recruitingMetastatic Breast Cancer
-
Artios Pharma LtdRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.RecruitingA Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the BrainMetastatic Breast CancerUnited States
-
SOLTI Breast Cancer Research GroupMerck Sharp & Dohme LLC; Pfizer; AstraZeneca; Astellas Pharma Inc; Advanced Accelerator... and other collaboratorsRecruiting
-
Neogene Therapeutics, Inc.RecruitingBreast Cancer | Pancreatic Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Colorectal Carcinoma | Other Solid TumorsUnited States
-
Tunisian Association for Immuno-oncology ResearchNot yet recruitingIdentify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
MedSIRDaiichi SankyoRecruitingMetastatic Breast Cancer | Solid Tumor, Adult | Advanced Non-Small Cell Squamous Lung CancerSpain, Austria
-
Sensei Biotherapeutics, Inc.Regeneron PharmaceuticalsRecruitingMelanoma | Sarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Bladder Cancer | Cervix Cancer | Advanced Solid Tumor | Advanced Cancer | Colon Cancer | Thyroid Cancer | Solid Tumor... and other conditionsUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingLocally Advanced or Metastatic Breast CancerChina
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Mexico, Brazil, Germany, Peru, Poland, Spain, Taiwan, South Africa, Czechia, Italy, Australia, Hungary
-
Genor Biopharma Co., Ltd.Recruiting
-
Sapience TherapeuticsRecruitingHepatocellular Carcinoma | Pancreatic Cancer | Ovarian Cancer | Cholangiocarcinoma | Triple Negative Breast Cancer | Metastatic Melanoma | Colon Cancer | Synovial Sarcoma | Breast Cancer Metastatic | Metastatic Colon Cancer | Melanoma Stage IV | Melanoma Recurrent | TNBC - Triple-Negative Breast Cancer | NSCLC, Metastatic and other conditionsUnited States
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recruiting
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Memorial Sloan Kettering Cancer CenterVarian Medical SystemsRecruitingMelanoma | Sarcoma | Renal Cell Carcinoma | Pancreatic Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Metastatic Solid Tumor | Gastrointestinal Cancer | Lobular Breast Carcinoma | Invasive Ductal Breast Carcinoma | Gastrointestinal Adenocarcinoma | Invasive Ductal Breast Carcinoma Stage IV | Lobular... and other conditionsUnited States